References
- Michel M, Otto-Erich O, Insel P. Peripheral adrenergic receptors in hypertension. Hyper 1990; 16: 107–120
- Barber R, Butcher R W. The egress of cyclic AMP from Metazoan cells. Advances in Cyclic Nucieotide Research, P. Greengard, G. Robinson. Raven Press. 1983; 119–135
- Brunton L L, Heasley L E. Cyclic AMP export and its regulation by prostaglandin A1. Methods in Enzymol 1988; 159: 83–93
- Wen S, Chang C, Reitherman R, Harding B. Characterization of cell surface adenosine 3′,5′-monophosphate-binding proteins in Y–1 mouse adrenal tumor cells. Endocrinol 1985; 116: 935–944
- Kleine L, Whitfield J. Serum-activated T51B rat liver cells transiently accumulate cyclic AMP-dependent protein kinases on their surfaces during G1 phase. J Cell Physiol 1987; 132: 354–358
- El Manigiarua, Wright G, McCumbee. Aortic cyclic AMP levels in hypertensive rats. Clin Exper Hyper 1989; A11: 75–87
- Chatelain R E. Elevated arterial cyclic AMP levels during the onset of renal hypertension in rats. Clin Science 1983; 64: 355–358
- Papagalanis N D, Skopelitis P, Kourti A, Kostogianni G, Karabatsos A, Gennadiou M, Thomas S, Samartzis M, Mountokalakis T. Urine calcium excretion, nephrogenous cyclic-adenosine monophosphate and serum parathyroid hormone levels in patients with essential hypertension. Nephron 1991; 59(2)226–31
- Mills P J, Dimsdale J E, Ziegler M G, Hauger R, Nelesen R A, Brown M. Sympathetic alterations following sodium restriction and short-term captopril. J Am Coll Cardiol 1993; 21: 177–181
- Metropolitan Life Foundation. 1983 Metropolitan height and weight tables. Stat Bull 1983; 64: 1
- Cinotti G A, Pugliese F. Prostaglandins and hypertension. Am J Hyper 1989; 2: 10s–15s
- Silver P J, Gordon R, Buchholz R, Dundore R, Ferguson E, Harris A, Pagini E. Comparative studies on cyclic nucleotide phosphodiesterases and inhibitors in experimental models of hypertension, congestive heart failure, and allergic asthma. Adv Second Messenger Phosphoprot Res 1992; 25: 341–351
- Bahner U, Palkovits M, Geiger H, Schmidt G, Heidland A. Adenylate cyclase-cyclic AMP-phosphodiesterase system in microdissected brain areas of normotensive and spontaneously hypertensive rats. J Chem Neuroanat 1989; 2: 45–55
- Kanter J R, Brunton L L. Inhibition of cyclic AMP efflux by insect pheromones and fatty acids. FEBS Letters 1989; 244: 149–153
- Fehr T, Dickinson E, Goldman S, Slakey L. Cyclic AMP efflux is regulated by occupancy of the adenosine receptor in pig aortic smooth muscle cells. J Biol Chem 1990; 265: 10974–10980
- Rutledge D R, Steinberg J, Cardozo L. Racial differences in drug response: Isoproterenol effects on heart rate following intravenous metoprolol. Clin Pharmacol Ther 1989; 45: 380–386
- Venter C, Daya P, Joubert P, Strydom W. Ethnic differences in human lymphocyte cyclic AMP production after isoprenaline stimulation and propranolol blockade. Br J Clin Pharmacol 1985; 19: 187–190
- Dimsdale J, Ziegler M, Graham R. The effect of hypertension, sodium, and race on isoproterenol sensitivity. Clin Exper Hyper 1988; A10(5)747–756
- Rutledge D R. Are there bT-adrenergic receptor response differences between racial groups?. DICP Ann Pharmacother 1991; 25: 824–834
- Mills P J, Dimsdale J E, Ziegler M. Rapid Publication: Lymphocyte basal cyclic AMP production predicts blood pressure. Clin Exper Hyper 1989; AII(3)521–530
- Weber A B. Cation transport markers as predictors of hypertension. Am J Hyper 1991; 4: 633s–637s
- Zicha J. Red cell ion transport abnormalities in experimental hypertension. Fund Clin Pharmacol 1993; 7: 129–141
- Nami R, Bianchini C, Aversa A, Gragnani S, Papini L, Peruzzi C, Lucani B, Perrone A F, Johnson S, Gennari C. Circulating levels of catecholamines and cyclic AMP during handgrip test in borderline hypertension. J Cardiovascular Pharmacol 1986; 8: 142s–144s